Blood cancers

Hodgkin lymphoma treatment gets the local nod

The use of ABVD chemotherapy for Hodgkin lymphoma has been endorsed as a mainline treatment with “excellent prognosis and manageable toxicity” in a new Australian retrospective study. The multi-centre study looked at 189 patients with previously untreated HL receiving ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) induction, between November 1999 and December 2014. Authors of the study, ...

Already a member?

Login to keep reading.

© 2021 the limbic